Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Bleakley

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Blood Advances|October 13, 2020
Naive T-cell depletion in stem cell transplantationMarie Bleakley
Blood|September 8, 2022
MDM2 inhibition augments GVL effectMarie Bleakley, Melinda Biernacki
Nature Reviews. Cancer|May 4, 2004
Molecules and mechanisms of the graft-versus-leukaemia effectMarie Bleakley, Stanley R Riddell
Frontiers in Immunology|March 3, 2020
Neoantigens in Hematologic MalignanciesMelinda A Biernacki, Marie Bleakley
Immunology and Cell Biology|February 9, 2011
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemiaMarie Bleakley, Stanley R Riddell
Blood|January 18, 2024
CD19 occupancy may drive CARs furtherAlexandre V Hirayama, Marie Bleakley
Expert Review of Hematology|December 12, 2024
Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignanciesMelinda A Biernacki, Marie Bleakley
Blood|February 27, 2025
Competition for CD19 binding may accelerate CAR efficacyAlexandre V Hirayama, Marie Bleakley
Blood Advances|July 2, 2026
Minor histocompatibility antigen TCR-TElizabeth F Krakow, Marie Bleakley
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell responseYongqing Li, Marie Bleakley, Cassian Yee
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Blood Advances|October 13, 2020
Naive T-cell depletion in stem cell transplantationMarie Bleakley
Blood|September 8, 2022
MDM2 inhibition augments GVL effectMarie Bleakley, Melinda Biernacki
Nature Reviews. Cancer|May 4, 2004
Molecules and mechanisms of the graft-versus-leukaemia effectMarie Bleakley, Stanley R Riddell
Frontiers in Immunology|March 3, 2020
Neoantigens in Hematologic MalignanciesMelinda A Biernacki, Marie Bleakley
Immunology and Cell Biology|February 9, 2011
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemiaMarie Bleakley, Stanley R Riddell
Blood|January 18, 2024
CD19 occupancy may drive CARs furtherAlexandre V Hirayama, Marie Bleakley
Expert Review of Hematology|December 12, 2024
Clinical trials, challenges, and changes in TCR-based therapeutics for hematologic malignanciesMelinda A Biernacki, Marie Bleakley
Blood|February 27, 2025
Competition for CD19 binding may accelerate CAR efficacyAlexandre V Hirayama, Marie Bleakley
Blood Advances|July 2, 2026
Minor histocompatibility antigen TCR-TElizabeth F Krakow, Marie Bleakley
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell responseYongqing Li, Marie Bleakley, Cassian Yee
Pageof 6